Azerbaijan vs Paraguay: The number of people with susceptibility test result for rifampicin
Azerbaijan
1,409
in 2021
Paraguay
1,639
in 2021
Azerbaijan rank
59th
Paraguay rank
56th
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Paraguay
How they compare
Paraguay currently reports 1,639 against 1,409 in Azerbaijan, a difference of 230.
That makes Paraguay's figure about 1.2 times Azerbaijan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Azerbaijan ahead.
Azerbaijan ranks 59th and Paraguay ranks 56th of 155 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,956 | 706 | 1,250 | Azerbaijan |
| 2020s | 1,327 | 1,204 | 123.5 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Paraguay?
- Paraguay, at 1,639 against 1,409 in Azerbaijan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Paraguay?
- 230, with Paraguay ahead.
- How many years of comparable data are there for Azerbaijan and Paraguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Paraguay rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th and Paraguay ranks 56th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.